To test whether IL-6 treatment could modulate TMPRSS6 mRNA expression in vitro, human hepatoma-derived Hep3B cells were treated with increasing doses of IL-6, and then HAMP and TMPRSS6 mRNA expression was evaluated by quantitative real-time PCR. Here, TMPRSS6 is linked to hepatocellular carcinoma.